IR Playbook pp 341-353 | Cite as

Infrainguinal Disease

  • Dylan Suttle
  • Luke R. Wilkins


Peripheral artery disease (PAD) is an exceedingly common disease attributed to multiple risk factors, most of which are modifiable. Clinical decisions regarding treatment options are dependent on the distribution and severity of PAD and the patient’s clinical presentation. This chapter is dedicated to discussing the diagnosis and management of atherosclerotic disease distal to the inguinal ligament. The approach to infrainguinal PAD treatment is multidisciplinary, with interventional radiology (IR) playing a pivotal role. It is from treating PAD that the field of IR was born, when in 1964 Dr. Charles Dotter successfully treated a woman’s non-healing foot ulcer with balloon angioplasty of an upstream arterial stenosis.


Peripheral artery disease (PAD) Angioplasty Stent Atherosclerosis Critical limb ischemia Claudication Acute limb ischemia Subintimal arterial flossing with antegrade-retrograde intervention (SAFARI) 


  1. 1.
    Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FGR. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg. 2007;45(1):S5–67.CrossRefGoogle Scholar
  2. 2.
    Hiatt WR. Medical treatment of peripheral arterial disease and claudication. N Engl J Med. 2001;344:1608–21.CrossRefPubMedGoogle Scholar
  3. 3.
    Newman AB, Shemanski L, Manolio TA, Cushman M, Mittlemark M, Polak JF, et al. Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. The Cardiovascular Health Study Group. Aterioscler Thromb Vasc Biol. 1999;19(3):538–45.CrossRefGoogle Scholar
  4. 4.
    Graham IM, Daly LE, Refsum H, Robinson K, Brattstrom LE, Uelan PM, et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA. 1997;277(22):1775–81.CrossRefPubMedGoogle Scholar
  5. 5.
    Singh RB, Mengi SA, Xu YJ, Arneja AS, Dhalla NS. Pathogenesis of atherosclerosis: a multifactorial process. Exp Clin Cardiol. 2002;7(1):40–53.PubMedPubMedCentralGoogle Scholar
  6. 6.
    Stary HC, Chandler B, Dinsmore RE, Fuster V, Glagov S, Insull W, et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. Circulation. 1995;92(5):1355–74.CrossRefPubMedGoogle Scholar
  7. 7.
    Selvin E, Marinopoulos S, Berkenbilt G, Rami T, Brancati FL, Powe NR, et al. Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med. 2004;141(6):421–31.CrossRefPubMedGoogle Scholar
  8. 8.
    Stary HC, Blankenhron DH, Chandler AB, Glagov S, Insull W, Richardson M. A definition of the intima of human arteries and of its atherosclerosis-prone regions. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation. 1992;85(1):391–405.CrossRefPubMedGoogle Scholar
  9. 9.
    Hansson G. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;325:1685–95.CrossRefGoogle Scholar
  10. 10.
    Rutherford RB, Baker JD, Ernst C, Johnston KW, Porter JM, Ahn S. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg. 2001;33(4):805.CrossRefGoogle Scholar
  11. 11.
    Selvin E, Erlinger T. Prevalence of a risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999–2000. Circulation. 2004;110(6):738–43.CrossRefPubMedGoogle Scholar
  12. 12.
    Rose GA, Blackburn H. Cardiovascular survey methods. Monogr Ser World Health Organ. 1968;56:1–188.PubMedGoogle Scholar
  13. 13.
    Kaufman JA, Lee MJ. The requisites: vascular and interventional radiology. 2nd ed. Philadelphia: Elsevier; 2014.Google Scholar
  14. 14.
    Geschwind JH, Dake MD. Abrams’ angiography: interventional radiology. 2nd ed. Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins Health; 2014.Google Scholar
  15. 15.
    Criqui MH, Fronek A, Klauber MR, Barrett-Conner E, Gabriel S. The sensitivity, specificity, and predictive value of traditional clinical evaluation of peripheral arterial disease: results from noninvasive testing in a defined population. Circulation. 1985;71(3):516–22.CrossRefPubMedGoogle Scholar
  16. 16.
    McKenna M, Wolfson S, Kuller L. The ratio of ankle and arm arterial pressure as an independent predictor of mortality. Atherosclerosis. 1991;87(2–3):119–28.CrossRefPubMedGoogle Scholar
  17. 17.
    Carmo GA, Mandil A, Nascimento BR, Arantes BD, Bittencourt JC, Flaqueto EB. Can we measure the ankle-brachial index using only a stethoscope? A pilot study. Fam Pr. 2009;26(1):22–6.CrossRefPubMedGoogle Scholar
  18. 18.
    Investigators THOPES. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med. 2000;342:145–53.CrossRefGoogle Scholar
  19. 19.
    Wilkins L, Sabri S. Strategies to approaching lower limb occlusions. Tech Vasc Interv Radiol. 2016;19(2):136–44.CrossRefPubMedGoogle Scholar
  20. 20.
    Kandarpa K, Machan L. Handbook of interventional radiologic procedures. 4th ed: Lippincott Williams & Wilkins; Philadelphia 2011.Google Scholar
  21. 21.
    Poirier P, Giles T, Bray G, Hong Y, Stern J, Pi-Sunyer F. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss. Aterioscler Thromb Vasc Biol. 2006;26:968–76.CrossRefGoogle Scholar
  22. 22.
    Muradin G, Bosch J, Stijnen T, Hunink M. Balloon dilation and stent implantation for treatment of femoropopliteal arterial disease: meta-analysis. Radiology. 2001;221(1):137–45.CrossRefPubMedGoogle Scholar
  23. 23.
    Bradbury A. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet. 2005;366:1925–34.CrossRefPubMedGoogle Scholar
  24. 24.
    Tepe G, Zeller T, Albrecht T, Heller S, Schwarzwalder U, Beregi J. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N Engl J Med. 2008;358(7):689–99.CrossRefPubMedGoogle Scholar
  25. 25.
    Scheinert D, Duda S, Zeller T, Krankenberg H, Ricke J, Bosiers M. The LEVANT 1 (Lutonix paclitaxel-coated balloon for the prevention of remoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty. JACC Cardiovasc Interv. 2014;7(1):10–9.CrossRefPubMedGoogle Scholar
  26. 26.
    Center for Devices and Radiological Health. Recently-Approved Devices - Endurant II/Endurant IIs Stent Graft System-P100021/S063 [Internet]. U S Food and Drug Administration Home Page. Center for Devices and Radiological Health; [cited 2018Mar23]. Available from:
  27. 27.
    Reekers J, Bolia A. Percutaneous intentional extraluminal (subintimal) recanalization: how to do it yourself. Eur J Radiol. 1998;28:192–8.CrossRefPubMedGoogle Scholar
  28. 28.
    Sabri S, Angle J, Spinosa D, Matsumoto ARE. Regarding the “SAFARI” technique: a word of caution (letter to the editor). Cardiovasc Intervent Radiol. 2010;33:1064–5.CrossRefPubMedGoogle Scholar
  29. 29.
    Hendricks N, Sabri S. Subintimal arterial flossing with antegrade-retrograde intervention (SAFARI) and retrograde access for critical limb ischemia. Tech Vasc Interv Radiol. 2014;17(3):203–10.CrossRefPubMedGoogle Scholar
  30. 30.
    Spinosa D, Harthun N, Bissonette E. Subintimal arterial flossing with antegrade-retrograde intervention (SAFARI) for subintimal recanalization to treat chronic critical limb ischemia. J Vasc Interv Radiol. 2005;16:37–44.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Radiology and Medical Imaging, Interventional RadiologyUniversity of Virginia Health SystemCharlottesvilleUSA
  2. 2.Department of Radiology and Medical ImagingUniversity of Virginia Health SystemCharlottesvilleUSA

Personalised recommendations